Some studies reported longer survival rates in CRC patients with high nuclear STAT1 and low nuclear STAT3 levels [37], and STAT1 was identified as belonging to a group of tightly co-regulated immune related genes that influence the tumor immunophenotype and are linked with disease-free survival in a cohort of colon cancer patients [10]. This evidence concerns the gene STAT3 and colorectal carcinoma.